Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0890
0.00 (0.00%)
At close: Aug 17, 2026
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $15.47 million as of August 18, 2026. Its market cap has increased by 124.07% in one year.
Market Cap
15.47M
Enterprise Value
15.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
ChartMarket Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 15.47M, an increase of 9.89%. That is a compound annual growth rate of 0.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 15.47M | 99.17% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 25.30M |
| Provectus Biopharmaceuticals | 23.05M |
| Oncotelic Therapeutics | 19.90M |
| ZIVO Bioscience | 17.81M |
| Finch Therapeutics Group | 16.22M |
| Synlogic | 14.27M |
| Anebulo Pharmaceuticals | 13.05M |
| Zeo ScientifiX | 10.97M |